Valuation: Astal Laboratories Limited

Market Cap 2.76B 28.98M 25.33M 23.26M 21.69M 41.11M 41.81M 280M 109M 1.35B 109M 106M 4.66B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.2M 26.38M 24.23M 22.59M 42.83M 43.56M 292M 113M 1.41B 113M 111M 4.86B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
38.01%
Yield 2024 *
-
Yield 2025 -
1 day-3.09%
1 week-2.74%
Current month-4.25%
1 month+26.89%
3 months+21.49%
6 months+0.79%
Current year-1.92%
1 week 82
Extreme 82
90.99
1 month 65.45
Extreme 65.45
91.3
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 22.41
Extreme 22.41
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 14/07/2023
Compliance Officer 32 18/04/2023
Director TitleAgeSince
Director/Board Member - 07/09/2022
Director/Board Member - 07/09/2022
Director/Board Member - 07/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-3.09%-2.74%+1.27%+194.74% 40.34M
+1.86%+7.65%+55.77%+158.84% 1,082B
+3.57%+7.42%+69.09%+58.92% 633B
+3.99%+7.37%+36.87%+93.77% 461B
+2.93%-1.94%+26.41%+20.22% 339B
-0.93%+0.56%+41.10%+38.79% 301B
-0.28%+1.06%+31.84%+44.14% 292B
-2.00%+2.33%-25.70%-39.89% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+4.21%+6.00%+17.72%+70.33% 163B
Average +0.91%+4.04%+28.04%+70.84% 369.98B
Weighted average by Cap. +1.27%+5.21%+41.66%+81.16%

Financials

2024 2025
Net sales 237M 2.49M 2.17M 1.99M 1.86M 3.53M 3.59M 24.01M 9.31M 116M 9.33M 9.13M 400M 637M 6.69M 5.84M 5.37M 5M 9.49M 9.65M 64.6M 25.03M 312M 25.11M 24.56M 1.08B
Net income 7.85M 82.43K 72.02K 66.14K 61.68K 117K 119K 796K 309K 3.85M 309K 303K 13.26M 89.25M 938K 819K 752K 702K 1.33M 1.35M 9.06M 3.51M 43.78M 3.52M 3.44M 151M
Net Debt -57.64M -605K -529K -486K -453K -859K -873K -5.85M -2.27M -28.27M -2.27M -2.22M -97.42M 115M 1.21M 1.06M 972K 907K 1.72M 1.75M 11.71M 4.54M 56.59M 4.55M 4.45M 195M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
03/07/26 85.18 -3.09% 23,395
02/07/26 ₹87.90 -0.16% 16,917
01/07/26 ₹88.04 -1.03% 41,626
30/06/26 ₹88.96 +1.58% 33,637
29/06/26 ₹87.58 -0.69% 115,777
  1. Stock Market
  2. Stocks
  3. MACINTR Stock